UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

Molecular cancer research, 2017-01, Vol.15 (1), p.78-92

2017

Volltextzugriff (PDF)

The Role of MicroRNAs in Ovarian Cancer

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

BMC cancer, 2018-11, Vol.18 (1), p.1065-1065, Article 1065

2018

Volltextzugriff (PDF)

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

PloS one, 2015-02, Vol.10 (2), p.e0118080-e0118080

2015

Volltextzugriff (PDF)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Scientific reports, 2015-12, Vol.5 (1), p.18217-18217, Article 18217

2015

Volltextzugriff (PDF)

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

Scientific reports, 2021-01, Vol.11 (1), p.2257-11, Article 2257

2021

Volltextzugriff (PDF)

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

Cancers, 2017-07, Vol.9 (7), p.83

2017

Volltextzugriff (PDF)

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2017-08, Vol.114 (35), p.E7301-E7310

2017

Volltextzugriff (PDF)

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

Cells (Basel, Switzerland), 2020-03, Vol.9 (4), p.814

2020

Volltextzugriff (PDF)

The highly metastatic nature of uterine cervical/endometrial cancer displaying tumor-related leukocytosis: clinical and preclinical investigations

Clinical cancer research, 2018-08, Vol.24 (16), p.4018-4029

2018

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Journal of ovarian research, 2018-09, Vol.11 (1), p.81-81, Article 81

2018

Volltextzugriff (PDF)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

Oncotarget, 2015-05, Vol.6 (13), p.11342-11356

2015

Volltextzugriff (PDF)

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

The American journal of pathology, 2013-05, Vol.182 (5), p.1876-1889

2013

Volltextzugriff (PDF)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Scientific reports, 2020-10, Vol.10 (1), p.16755, Article 16755

2020

Volltextzugriff (PDF)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

PloS one, 2016-03, Vol.11 (3), p.e0151050-e0151050

2016

Volltextzugriff (PDF)

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Oncotarget, 2018-11, Vol.9 (91), p.36317-36330

2018

Volltextzugriff (PDF)

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Clinical cancer research, 2011-06, Vol.17 (12), p.4042-4051

2011

Volltextzugriff (PDF)

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5413-5424

2021

Volltextzugriff (PDF)

Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report

Case reports in women's health, 2024-03, Vol.41, p.e00589, Article e00589

2024

Volltextzugriff (PDF)

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical cancer research, 2009-09, Vol.15 (17), p.5404-5413

2009

Volltextzugriff (PDF)

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

Thrombosis journal, 2023-05, Vol.21 (1), p.57-57, Article 57

2023

Volltextzugriff (PDF)

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

Oncoimmunology, 2019-12, Vol.8 (12), p.e1662708-e1662708

2019

Volltextzugriff (PDF)

A 3-year follow-up study of radiotherapy using computed tomography–based image-guided brachytherapy for cervical cancer

Journal of radiation research, 2019-03, Vol.60 (2), p.264-269

2019

Volltextzugriff (PDF)

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (4), p.1670-1679

2007

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(143)

Publikationsform

Artikel
(147)
Berichte
(4)

Sprache

Englisch
(146)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

The Role of MicroRNAs in Ovarian Cancer

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

The highly metastatic nature of uterine cervical/endometrial cancer displaying tumor-related leukocytosis: clinical and preclinical investigations

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

A 3-year follow-up study of radiotherapy using computed tomography–based image-guided brachytherapy for cervical cancer

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

Aktive Filter

Suchergebnisse filtern